JNJ-47965567

CAS : 1428327-31-4

Ref. 3D-DHC32731

Informations sur le produit

• Nom: JNJ-47965567
• Marque: Biosynth
• Description: JNJ-47965567 is a selective P2X7 receptor antagonist, which is derived from a rigorous screening of chemical libraries to target purinergic signaling pathways. Its mode of action involves competitive inhibition of the P2X7 receptor, a ligand-gated ion channel activated by extracellular ATP. This receptor is predominantly expressed in immune cells and is implicated in the release of pro-inflammatory cytokines.The primary applications of JNJ-47965567 lie in its potential therapeutic role in conditions where excessive inflammation is a contributing factor. Specifically, it is studied for its ability to modulate immune responses, with implications in autoimmune diseases, neurodegenerative disorders, and chronic pain. The specificity and efficacy of JNJ-47965567 as an antagonist allow it to serve as a valuable tool in elucidating P2X7 receptor function and its involvement in pathological processes. Research involving JNJ-47965567 continues to probe its pharmacodynamics and possible integration into therapeutic strategies targeting inflammation-driven diseases.

Propriétés chimiques

• Masse moléculaire: 488.64 g/mol
• Formule: C₂₈H₃₂N₄O₂S
• Degré de pureté: Min. 95%